REGENERON PHARMACEUTICALS, INC.: revenue
| Value | {"amount": 445824000, "concept": "us-gaap:Revenues", "currency": "USD"} |
|---|---|
| Period | 2011-01-01 – 2011-12-31 |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-09-01T12:57:22.486063+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e12a3779-daf5-4a99-a638-dc380ae7009d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001206774-12-000709Retrieved: 2026-09-01T12:57:22.486063+02:00
Raw response sha256:
8ac8537cd8b5e571e7f527aae3e223c6…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/revenue/2011-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e12a3779-daf5-4a99-a638-dc380ae7009d
History
- supersedes {"amount": 44686000, "concept": "us-gaap:SalesRevenueGoodsNet", "currency": "USD"} (evidence 0001206774-12-000709)